Northeast Pharmaceutical: First-instance judgment of contract dispute case, need to pay breach of contract damages of 16.45 million yuan.

Northeast Pharmaceutical announced that the Uhai Shuangqing vs. Northeast Pharmaceutical and Uhai Chemical contract dispute case has been concluded. Uhai Shuangqing requested Northeast Pharmaceutical and Uhai Chemical to jointly compensate for economic losses of 32.7 million yuan, default interest losses of 25.1452 million yuan, etc. The court of first instance ruled that Northeast Pharmaceutical should pay Uhai Shuangqing 16.45 million yuan for breach of contract, and dismissed other claims. The court acceptance fee was 331,000 yuan, with Northeast Pharmaceutical bearing 120,500 yuan. The company will appeal in accordance with the law, and the impact of the litigation on profits is uncertain.